Gadofosveset Trisodium

Gadofosveset Trisodium Overview

Gadofosveset (trade names Vasovist, Ablavar) is a gadolinium-based MRI contrast agent. It was used as the trisodium salt monohydrate form.[1][2] It acts as a blood pool agent by binding to human serum albumin. The manufacturer (Lantheus Medical) discontinued production in 2017 due to poor sales.[3] References ^ DailyMed: Vasovist ^ Drugs.com: Ablavar ^ Bell, Daniel; Morgan, Matt. "Gadofosveset trisodium". Radiopaedia. radiopaedia.org. Ret...

Read more Gadofosveset Trisodium Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Gadofosveset

Recent Gadofosveset Trisodium Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Gadofosveset Trisodium

Injection: 244mg
Solution: 2440mg/10ml (244mg/ml), 3660mg/15ml (244mg/ml)

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Gadofosveset Trisodium: (1 result)

Sorted by National Drug Code

11994-012 Ablavar 244 mg/ml Intravenous Injection, Solution by Lantheus Medical Imaging, Inc.

Other drugs which contain Gadofosveset Trisodium or a similar ingredient: (1 result)

VASOVIST Gadofosveset Trisodium